Limonene: The Same Number, Two Very Different Exposures

Limonene is a cyclic monoterpene: ten carbons, no oxygen in the molecule, a boiling point around 176 degrees Celsius at atmospheric pressure, and very low water solubility. Almost everything below follows from those three facts.

Low molecular weight and no oxygen make it volatile. It leaves material at room temperature, and faster when warmed. Its lipophilicity means it partitions into fats and membranes rather than into water. And its boiling point sits well below that of the heavier constituents it shares the material with.

None of this is exotic chemistry. It is the ordinary behaviour of a small terpene, and it is the reason the limonene figure is the least stable number on a certificate.

Heating material does not release its constituents all at once and in proportion. It releases them in an order set by volatility, which means the composition of what leaves the material changes continuously as temperature rises and as use continues.

For limonene the consequence is that it comes off early and it comes off fast. Material whose certificate reports a substantial limonene fraction gives up a disproportionate share of it at the start, and progressively less afterwards, because a finite amount is being depleted.

There is a second implication that gets less attention. Temperature is not a neutral setting. A lower one favours the lighter, more volatile constituents; a higher one brings heavier ones into play while driving the lighter ones off faster. The profile on the certificate is a property of the material. What actually reaches the person is a property of the material and the temperature together, and the certificate has no knowledge of the second.

Swallowing changes the question entirely.

An orally administered compound is absorbed through the gut wall and travels via the portal vein to the liver before it reaches general circulation. For limonene this matters more than for most constituents, because it is extensively metabolised — oxidised at several positions — so a substantial proportion of what enters circulation after an oral dose is not limonene but its metabolites.

By that route, then, the limonene figure describes something that largely does not survive the journey in the form named on the page. That is not a criticism of the measurement. The measurement is of the material, and it is accurate about the material. It is a statement about how far the measurement can be carried.

There is an article on this site about why oral toxicology numbers do not transfer to inhaled exposure, written about pesticide residues. The reasoning is identical, and the fact that it is identical is worth noticing, because it means the principle is general rather than special pleading for one compound.

Acceptable daily intakes and reference doses are derived from feeding studies and describe swallowing. Inhaled compounds cross the alveolar membrane directly into arterial blood, and the liver's turn comes afterwards, once the compound has already circulated. The United States EPA's own guidance is explicit that oral data should not be used for route-to-route extrapolation where a first-pass effect is expected.

Limonene is exactly such a compound. Most of what is known about it comes from oral studies, and that knowledge does not transfer unmodified to an inhaled route. Nobody has done the work of establishing the conversion.

None of this makes the number useless. It makes it a measurement of one thing rather than of another.

It is a good indicator of how fresh material is, precisely because limonene is among the first constituents to decline. It is a reasonable batch-to-batch comparator, provided the batches went through the same method. And a certificate that reports it at all is evidence the material was characterised rather than assumed.

What it is not is a description of exposure. Identical certificates, used by different routes, deliver different compounds in different proportions to different tissues. The certificate is the same. The exposure is not.

The question this raises is answerable, and it is worth setting out what answering it would take, because "more research is needed" is not a finding.

For the inhaled route you would need transfer efficiency: what fraction of the limonene present in material actually reaches the user, across the temperature range in ordinary use. That is a bench measurement rather than a clinical trial, and equivalent work has been done for other compounds on other materials.

For the oral route you would need pharmacokinetics at realistic quantities: absorption, the proportion surviving first pass, and the metabolite profile that results.

With those two sets of numbers a certificate could be converted into an estimate of exposure. Without them it cannot, and the honest position is that the conversion factors do not exist — not that they are small.

Is this certificate for the batch actually supplied, and when was it tested?

What is the material intended for, and does any of the documentation address delivery rather than composition?

Where heat is involved, has anyone measured what temperature does to this profile?

Those are questions about a supply chain rather than about chemistry. They are the ones a careful reader arrives at once the chemistry is clear, and they are answerable by whoever supplies the material.